Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment

'מערכת אימד' 09/11/2016 12:36

Highlights

• Many patients with MDD experience symptoms that impair functioning and productivity.
• Brexpiprazole+ADT was studied in young patients with MDD who were at work/school.
• Depressive symptoms and functioning improved over the 12–week study.
• Adjunctive brexpiprazole was well tolerated.

Richard H. Weisleret al., Journal of Affective Disorders, Volume 204, 2016, Pages 40-47, ISSN 0165-0327,
https://doi.org/10.1016/j.jad.2016.06.001.